Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy
dc.contributor.author | Jaikuna T. | |
dc.contributor.author | Osorio E.V. | |
dc.contributor.author | Azria D. | |
dc.contributor.author | Chang-Claude J. | |
dc.contributor.author | De Santis M.C. | |
dc.contributor.author | Gutiérrez-Enríquez S. | |
dc.contributor.author | van Herk M. | |
dc.contributor.author | Hoskin P. | |
dc.contributor.author | Lambrecht M. | |
dc.contributor.author | Lingard Z. | |
dc.contributor.author | Seibold P. | |
dc.contributor.author | Seoane A. | |
dc.contributor.author | Sperk E. | |
dc.contributor.author | Symonds R.P. | |
dc.contributor.author | Talbot C.J. | |
dc.contributor.author | Rancati T. | |
dc.contributor.author | Rattay T. | |
dc.contributor.author | Reyes V. | |
dc.contributor.author | Rosenstein B.S. | |
dc.contributor.author | de Ruysscher D. | |
dc.contributor.author | Vega A. | |
dc.contributor.author | Veldeman L. | |
dc.contributor.author | Webb A. | |
dc.contributor.author | West C.M.L. | |
dc.contributor.author | Aznar M.C. | |
dc.contributor.other | Mahidol University | |
dc.date.accessioned | 2023-09-21T18:01:03Z | |
dc.date.available | 2023-09-21T18:01:03Z | |
dc.date.issued | 2023-12-01 | |
dc.description.abstract | Background: Normal tissue complication probability (NTCP) models can be useful to estimate the risk of fibrosis after breast-conserving surgery (BCS) and radiotherapy (RT) to the breast. However, they are subject to uncertainties. We present the impact of contouring variation on the prediction of fibrosis. Materials and methods: 280 breast cancer patients treated BCS-RT were included. Nine Clinical Target Volume (CTV) contours were created for each patient: i) CTV_crop (reference), cropped 5 mm from the skin and ii) CTV_skin, uncropped and including the skin, iii) segmenting the 95% isodose (Iso95%) and iv) 3 different auto-contouring atlases generating uncropped and cropped contours (Atlas_skin/Atlas_crop). To illustrate the impact of contour variation on NTCP estimates, we applied two equations predicting fibrosis grade ≥ 2 at 5 years, based on Lyman-Kutcher-Burman (LKB) and Relative Seriality (RS) models, respectively, to each contour. Differences were evaluated using repeated-measures ANOVA. For completeness, the association between observed fibrosis events and NTCP estimates was also evaluated using logistic regression. Results: There were minimal differences between contours when the same contouring approach was followed (cropped and uncropped). CTV_skin and Atlas_skin contours had lower NTCP estimates (−3.92%, IQR 4.00, p < 0.05) compared to CTV_crop. No significant difference was observed for Atlas_crop and Iso95% contours compared to CTV_crop. For the whole cohort, NTCP estimates varied between 5.3% and 49.5% (LKB) or 2.2% and 49.6% (RS) depending on the choice of contours. NTCP estimates for individual patients varied by up to a factor of 4. Estimates from “skin” contours showed higher agreement with observed events. Conclusion: Contour variations can lead to significantly different NTCP estimates for breast fibrosis, highlighting the importance of standardising breast contours before developing and/or applying NTCP models. | |
dc.identifier.citation | Breast Vol.72 (2023) | |
dc.identifier.doi | 10.1016/j.breast.2023.103578 | |
dc.identifier.eissn | 15323080 | |
dc.identifier.issn | 09609776 | |
dc.identifier.scopus | 2-s2.0-85170699959 | |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/90075 | |
dc.rights.holder | SCOPUS | |
dc.subject | Biochemistry, Genetics and Molecular Biology | |
dc.title | Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy | |
dc.type | Article | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85170699959&origin=inward | |
oaire.citation.title | Breast | |
oaire.citation.volume | 72 | |
oairecerif.author.affiliation | Instituto de Investigación Sanitaria de Santiago de Compostela | |
oairecerif.author.affiliation | Medizinische Fakultät Mannheim | |
oairecerif.author.affiliation | Siriraj Hospital | |
oairecerif.author.affiliation | College of Life Sciences | |
oairecerif.author.affiliation | Vall d‘Hebron Institut de Oncologia | |
oairecerif.author.affiliation | Université de Montpellier | |
oairecerif.author.affiliation | Centro de Investigación Biomédica en Red de Enfermedades Raras | |
oairecerif.author.affiliation | Universitair Ziekenhuis Gent | |
oairecerif.author.affiliation | University of Leicester | |
oairecerif.author.affiliation | KU Leuven | |
oairecerif.author.affiliation | German Cancer Research Center | |
oairecerif.author.affiliation | School of Medical Sciences | |
oairecerif.author.affiliation | Icahn School of Medicine at Mount Sinai | |
oairecerif.author.affiliation | Hospital Universitari Vall d'Hebron | |
oairecerif.author.affiliation | Maastricht Universitair Medisch Centrum+ | |
oairecerif.author.affiliation | Fondazione IRCCS Istituto Nazionale dei Tumori, Milan | |
oairecerif.author.affiliation | Universitätsklinikum Hamburg-Eppendorf | |
oairecerif.author.affiliation | Fondazione IRCCS Nazionale dei Tumori | |
oairecerif.author.affiliation | Grupo de Medicina Xenómica (USC) |